These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10485899)

  • 41. Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.
    Carvajal-Rodríguez A; Crandall KA; Posada D
    Infect Genet Evol; 2007 Jul; 7(4):476-83. PubMed ID: 17369105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deterministic and stochastic regimes of asexual evolution on rugged fitness landscapes.
    Jain K; Krug J
    Genetics; 2007 Mar; 175(3):1275-88. PubMed ID: 17179085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fitness landscape of human immunodeficiency virus type 1 protease quasispecies.
    Fernàndez G; Clotet B; Martínez MA
    J Virol; 2007 Mar; 81(5):2485-96. PubMed ID: 17151104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential turnover of human immunodeficiency virus type 1 env throughout the course of infection.
    Riddle TM; Shire NJ; Sherman MS; Franco KF; Sheppard HW; Nelson JA
    J Virol; 2006 Nov; 80(21):10591-9. PubMed ID: 16956948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trials.
    Wick WD; Gilbert PB; Self SG
    PLoS Comput Biol; 2006 Jun; 2(6):e64. PubMed ID: 16789816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the effects of human mixing patterns on human immunodeficiency virus-1 interhost phylogenetics through social network simulation.
    Goodreau SM
    Genetics; 2006 Apr; 172(4):2033-45. PubMed ID: 16636112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA interference: its use as antiviral therapy.
    Haasnoot J; Berkhout B
    Handb Exp Pharmacol; 2006; 173(173):117-50. PubMed ID: 16594614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interplay between virus infection and the cellular RNA interference machinery.
    Berkhout B; Haasnoot J
    FEBS Lett; 2006 May; 580(12):2896-902. PubMed ID: 16563388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1.
    Althaus CL; Bonhoeffer S
    J Virol; 2005 Nov; 79(21):13572-8. PubMed ID: 16227277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution of human immunodeficiency virus under selection and weak recombination.
    Rouzine IM; Coffin JM
    Genetics; 2005 May; 170(1):7-18. PubMed ID: 15744057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for positive selection on Mycobacterium tuberculosis within patients.
    Tanaka MM
    BMC Evol Biol; 2004 Sep; 4():31. PubMed ID: 15355550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.
    Persaud D; Siberry GK; Ahonkhai A; Kajdas J; Monie D; Hutton N; Watson DC; Quinn TC; Ray SC; Siliciano RF
    J Virol; 2004 Jan; 78(2):968-79. PubMed ID: 14694128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of population bottlenecks during systemic movement of tobacco mosaic virus in tobacco plants.
    Sacristán S; Malpica JM; Fraile A; García-Arenal F
    J Virol; 2003 Sep; 77(18):9906-11. PubMed ID: 12941900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus.
    Briones C; Domingo E; Molina-París C
    J Mol Biol; 2003 Aug; 331(1):213-29. PubMed ID: 12875847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS.
    Liu SL; Mittler JE; Nickle DC; Mulvania TM; Shriner D; Rodrigo AG; Kosloff B; He X; Corey L; Mullins JI
    J Virol; 2002 Nov; 76(21):10674-84. PubMed ID: 12368309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotypic testing for human immunodeficiency virus type 1 drug resistance.
    Shafer RW
    Clin Microbiol Rev; 2002 Apr; 15(2):247-77. PubMed ID: 11932232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and temporal dynamics of populations within wheat streak mosaic virus isolates.
    Hall JS; French R; Morris TJ; Stenger DC
    J Virol; 2001 Nov; 75(21):10231-43. PubMed ID: 11581391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.
    Doukhan L; Delwart E
    J Virol; 2001 Jul; 75(14):6729-36. PubMed ID: 11413343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic drift and within-host metapopulation dynamics of HIV-1 infection.
    Frost SD; Dumaurier MJ; Wain-Hobson S; Brown AJ
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6975-80. PubMed ID: 11381143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.
    Rouzine IM; Rodrigo A; Coffin JM
    Microbiol Mol Biol Rev; 2001 Mar; 65(1):151-85. PubMed ID: 11238990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.